# Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

> **NCT07219004** · NA · COMPLETED · sponsor: **Tides Medical** · enrollment: 30 (actual)

## Conditions studied

- Lower Extremity Chronic Ulcers in Diabetics
- Diabetic Foot Ulcer (DFU)

## Interventions

- **OTHER:** amniotic membrane

## Key facts

- **NCT ID:** NCT07219004
- **Lead sponsor:** Tides Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-03
- **Primary completion:** 2023-09-27
- **Final completion:** 2023-09-27
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07219004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07219004, "Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07219004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*